Publicações de Renato D. Lopes [8]

Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial

Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve

N Engl J Med 383;22 DOI: 10.1056/NEJMoa2029603

A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial

American Heart Journal, vol. 231 Doi: 10.1016/j.ahj.2020.10.001

Insulin Use and Clinical Outcomes in Patients Undergoing Coronary Artery Bypass Graft Surgery

Braz J Cardiovasc Surg. 2020 Oct 1;35(5):666-674. Doi: 10.21470/1678-9741-2019-0347

Association of the left common ostium with clinical outcome after pulmonary vein isolation in atrial fibrillation

Indian Pacing Electrophysiol J ; 2020 Nov 30. Doi: 10.1016/j.ipej.2020.11.020

Treating periodontal disease in patients with myocardial infarction: A randomized clinical trial

European Journal of Internal Medicine 71 (2020) 76–80 DOI: 10.1016/j.ejim.2019.08.012

RATIONALE AND DESIGN OF THE STATINS EVALUATION IN CORONARY PROCEDURES AND REVASCULARIZATION: THE SECURE-PCI TRIAL

Am Heart J. 2018;198:129-134. ISSN 0002-8703 DOI: 10.1016/j.ahj.2017.12.018

CLOPIDOGREL USE AFTER MYOCARDIAL REVASCULARIZATION: PREVALENCE, PREDICTORS, AND ONE-YEAR SURVIVAL RATE

Brazilian Journal of Cardiovascular Surgery, 2016;31(2):106-114 – ISSN: 1678-9741 DOI: 10.5935/1678-9741.20160019